19 May 2013
Keywords: roche, avastin, cleared, ec, swiss, drug, major
Article | 24 January 2005
Swiss drug major Roche says that the European Commission has approved its Avastin (bevacizumab) for the treatment of colorectal cancer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.